| Not Yet Recruiting | 18F-PSMA PET/CT Versus CT Alone in Assessment of Prostatic Cancer Patients NCT07485881 | Assiut University | — |
| Not Yet Recruiting | Lab Research Using Mini-tumors to Study Prostate Cancer Treatments NCT07004582 | Maastricht Radiation Oncology | — |
| Recruiting | Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors NCT07410494 | Essen Biotech | Phase 1 / Phase 2 |
| Recruiting | Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Me NCT06957691 | Shehzad Basaria, M.D. | Phase 2 |
| Recruiting | Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy NCT07131956 | University of Erlangen-Nürnberg Medical School | — |
| Recruiting | 64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of NCT06970847 | Clarity Pharmaceuticals Ltd | Phase 3 |
| Not Yet Recruiting | A Multicenter, Open-label, Prospective Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imagin NCT06922929 | Yunhe Pharmaceutical (Tianjin) Co., Ltd | Phase 3 |
| Withdrawn | Using Meditation for Oncology Anxiety NCT04312191 | Mellar Davis MD | N/A |
| Recruiting | Salvage MR-guided High-Dose-Rate Brachytherapy for Prostate Bed Recurrence After Radiotherapy in the PSMA PET NCT06508567 | University Health Network, Toronto | N/A |
| Recruiting | PSMA-RLT in Biochemically Recurrent PCa NCT06220188 | Medical University of Vienna | Phase 2 |
| Completed | A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant NCT05848011 | MacroGenics | Phase 2 |
| Recruiting | Antibody CC-1 in Men With Biochemical Recurrence of Prostate Cancer NCT05646550 | University Hospital Tuebingen | Phase 1 |
| Recruiting | Metastasis-directed Therapy for Oligorecurrent Prostate Cancer NCT05352178 | Universitaire Ziekenhuizen KU Leuven | Phase 3 |
| Recruiting | COAST Therapy in Advanced Solid Tumors and Prostate Cancer NCT05036226 | Medical University of South Carolina | Phase 1 / Phase 2 |
| Completed | Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer NCT04742361 | ABX advanced biochemical compounds GmbH | Phase 3 |
| Unknown | MBM-02 (Tempol) for the Treatment of Biochemical Recurrent Prostate Cancer NCT04876755 | Matrix Biomed, Inc. | Phase 2 |
| Completed | An AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's Contin NCT05384002 | Fondazione del Piemonte per l'Oncologia | — |
| Unknown | Stereotactic Body Radiotherapy With or Without Darolutamide for OligoRecurrent Prostate Cancer NCT04641078 | University Hospital, Ghent | Phase 2 |
| Recruiting | PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHE NCT05022914 | Azienda Ospedaliero-Universitaria Careggi | — |
| Completed | Safety and Efficacy of [18F]PSMA-1007 Injection in Suspected Persistent or Recurrent Prostate Cancer. NCT04644822 | Centre for Probe Development and Commercialization | Phase 3 |
| Unknown | Exploring the Mechanisms and Dynamics of Clonal Evolution Leading to Recurrence in Prostate Cancer NCT04686188 | Institute of Cancer Research, United Kingdom | — |
| Unknown | Molecular Profiling in Prostate Cancer NCT04983628 | Hellenic Cooperative Oncology Group | — |
| Completed | Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancer NCT04428203 | Zin W Myint | Phase 1 |
| Unknown | A Prospective Study on 18F-DCFPyL PET/CT Imaging in Biochemical Recurrence of Prostate Cancer NCT04734184 | Curium PET France | Phase 3 |
| Completed | Identification of Predictive Biomarkers NCT04324983 | Martini-Klinik am UKE GmbH | N/A |
| Unknown | F18-PSMA-1007 PET for Early Biochemical Recurrence of Prostate Cancer NCT04239742 | Radboud University Medical Center | N/A |
| Completed | Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer NCT04011410 | Patrick Hensley | Phase 2 |
| Active Not Recruiting | Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer NCT04114825 | RhoVac APS | Phase 2 |
| Completed | The Role of Follicle Stimulating Hormone in Advanced Prostate Cancer NCT04134130 | Lund University | N/A |
| Completed | F-18-PSMA-1007 Versus F-18-Fluorocholine PET in Patients With Biochemical Recurrence NCT04102553 | ABX advanced biochemical compounds GmbH | Phase 3 |
| Completed | Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer NCT03739684 | Progenics Pharmaceuticals, Inc. | Phase 3 |
| Active Not Recruiting | Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer NCT03444844 | Five Eleven Pharma, Inc. | Phase 1 / Phase 2 |
| Completed | Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence NCT03396874 | University of Michigan | Phase 2 |
| Terminated | HDR Brachytherapy, EBRT and STAD for the Treatment of Prostate Cancer NCT03553602 | Loyola University | Phase 1 / Phase 2 |
| Completed | Sipuleucel-T and Low-protein Diet in Patients With Metastatic Castrate-resistant Prostate Cancer NCT03329742 | Indiana University | N/A |
| Unknown | Evaluation of the Metastasis and Recurrence of Prostate Cancer NCT03507595 | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | — |
| Completed | Study of 68Ga-HBED-PSMA PET/CT and Conventional Imaging in Occult Biological Relapse Prostate Cancer NCT03443609 | Institut Cancerologie de l'Ouest | N/A |
| Completed | Salvage Lymph Node Dissection in Prostate Cancer Patients With Recurrence After Radical Prostatectomy NCT02974075 | Medical University of Vienna | N/A |
| Active Not Recruiting | PET-MR-PSA Prostate Cancer Recidive Study NCT02562131 | Norwegian University of Science and Technology | — |
| Active Not Recruiting | Pilot Study of Whole Gland Salvage HDR Prostate Brachytherapy for Locally Recurrent Prostate Cancer NCT02560181 | Sunnybrook Health Sciences Centre | N/A |
| Completed | Metformin Prostate Cancer Adjuvant Trial NCT02176161 | NYU Langone Health | Phase 2 |
| Unknown | Development of Clinical Assessment Technique Using Multi-radiotracer PET/MR in Prostate Cancer NCT01938339 | Seoul National University Hospital | N/A |
| Terminated | Firmagon (Degarelix) Intermittent Therapy NCT01512472 | Canadian Urology Research Consortium | Phase 4 |
| Completed | Post-radiation Prostate Cancer Local Recurrences: Detection With Histoscanning™ and MRI NCT01857037 | Hospices Civils de Lyon | N/A |
| Completed | SBRT for Oligometastatic Lymph Node Recurrence in Prostate Cancer: a Single Institution Experience NCT03604211 | Kantonsspital Graubuenden | — |
| Approved For Marketing | Expanded Access Protocol of 68Ga PSMA 11 PET Imaging of Prostate Cancer NCT04452136 | Jeanne Link | — |
| No Longer Available | Clinical Use of 68Ga PSMA-11 PET/CT in Diagnosing, Staging and Restaging Prostate Cancer NCT05002465 | Dana Mathews | — |